Aspen is a place for leaders to lift their sights above the possessions which possess them. To confront their own nature as human beings, to regain control over their own humanity by becoming more self-aware, more self-correcting, and hence more self-fulfilling.
Walter P. Paepcke, Aspen Institute Co-Founder
Aspen Institute
Blog Posts, and Videos
Powering Vaccine R&D: A Discussion on the Future of the Global Ecosystem for Vaccine R&D
May 7, 2021
The rapid development of COVID-19 vaccines is fueling a reimagining of what is possible for vaccine research and development (R&D). Join us for a panel discussion and Q&A reflecting on ideas offered in a forthcoming report by the Sabin-Aspen Vaccine Science & Policy Group, Powering Vaccine R&D: Opportunities for Transformation. This report will draw on historic lessons learned from vaccine development to outline opportunities to overhaul vaccine R&D practices to better prepare for the next pandemic, to make strides against diseases currently without vaccines, and to establish next-generation vaccines that offer meaningful improvements. Expert panelists will reflect on what it will take to transform the vaccine R&D ecosystem and how stakeholders at all levels can help support those efforts.
FEATURING:
Brief overview of report by Dr. Bruce Gellin, President of Global Immunization, Sabin Vaccine Institute; member, Sabin-Aspen Vaccine Science & Policy Group Panel discussion moderated by Jamie Bay Nishi, Director, Global Health Technologies Coalition (GHTC), featuring:
Dr. Kundai Chinyenze, Executive Medical Director, IAVI, Uganda
Dr. Penny Heaton, Chief Executive Officer, Bill & Melinda Gates Medical Research Institute; member, Sabin-Aspen Vaccine Science & Policy Group
Dr. John Nkengasong, Director, Africa Centres for Disease Control and Prevention
Prof. Helen Rees, Executive Director, Wits Reproductive Health and HIV Institute, University of the Witwatersrand; member, Sabin-Aspen Vaccine Science & Policy Group
